Document Type : Original Article


1 Non-communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2 Department of Social Medicine, Jahrom University of Medical Sciences, Jahrom, Iran

3 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

4 Department of Health Education and Health Promotion, School of Health, Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran

5 Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

6 Neonatal and Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran


Background: HIV, Tuberculosis, and Malariaare neglected due to the high pressure imposed on healthcare systems by COVID-19; however, since these diseases afflict a large number of patients globally, their effect on COVID-19, as a world pandemic, should be assessed. We aimed to assess the relationship between the prevalence of these diseases and COVID-19 indices.
Methods: In this ecological study, a data set was provided, which included the epidemiologic indices of COVID-19 for each country. The scatter plots of the social capital for the studied countries based on the epidemiologic indices of COVID-19 and HIV (human immunodeficiency virus), and Malaria were drawn.
Results: The prevalence of HIV, Tuberculosis, and Malaria were inversely correlated with the cumulative incidence rate of cases, the cumulative incidence rate of death, and COVID-19 tests performed per million, and was directly correlated with the recovery rate. No correlation was seen between case fatality rate and the prevalence of these infectious diseases.
Conclusion: However, the results of this study were in favor of people afflicted with HIV, and Further studies should be conducted on the concurrence of infectious events and their adverse consequences with future analytical protocols.


  1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. PMID: 32081636; PMCID: PMC7127800.
  2. Zimmermann LV, Salvatore M, Babu GR, Mukherjee B. Estimating COVID-19‒related mortality in India: an epidemiological challenge with insufficient data. Am J Public Health. 2021 Jul;111(S2):S59-62. doi: 10.2105/AJPH.2021.306419. PMID: 34314196; PMCID: PMC8495647.
  3. Moore SC, Penrice-Randal R. Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism. Viruses. 2020;12(10). doi: 10.3390/v12101164. PMID: 33066701; PMCID: PMC7602519.
  4. Tay MZ, Poh CM, Rénia L. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363-74. doi: 10.1038/s41577-020-0311-8. PMID: 32346093; PMCID: PMC7187672.
  5. Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, Tuberculosis, and Malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132-e41. doi: 10.1016/S2214-109X(20)30288-6. PMID: 32673577; PMCID: PMC7357988.
  6. Madan M, Pahuja S, Mohan A, Pandey RM, Madan K, Hadda V, et al. TB infection and BCG vaccination: are we protected from COVID-19? Public health. 2020;185:91-2. doi: 10.1016/j.puhe.2020.05.042. PMID: 32590235; PMCID: PMC7260483.
  7. Di Gennaro F, Marotta C, Locantore P. Malaria and COVID-19: Common and Different Findings. Trop Med Infect Dis. 2020;5(3). doi: 10.3390/tropicalmed5030141. PMID: 32899935; PMCID: PMC7559940.
  8. Wang J, Xu C, Wong YK, He Y, Adegnika AA, Kremsner PG, et al. Preparedness is essential for Malaria-endemic regions during the COVID-19 pandemic. Lancet (London, England). 2020;395(10230):1094-6. doi: 10.1016/S0140-6736(20)30561-4. PMID: 32192582; PMCID: PMC7158917.
  9. Lei ZN, Wu ZX, Dong S, Yang DH, Zhang L, Ke Z, et al. Chloroquine and hydroxychloroquine in the treatment of Malaria and repurposing in treating COVID-19. Pharmacol Ther. 2020;216:107672. doi: 10.1016/j.pharmthera.2020.107672. PMID: 32910933; PMCID: PMC7476892.
  10. Giroir BP. The Time Is Now to End the HIV Epidemic. Am J Public Health. 2020;110(1):22-4. doi: 10.2105/AJPH.2019.305380. PMID: 31725312; PMCID: PMC6893354.
  11. Bartilotti Matos F, Davies P. Pearls and pitfalls: Two contrasting HIV diagnoses in the COVID-19 era and the case for screening. J Med Virol. 2021;93(2):652-4. doi: 10.1002/jmv.26428. PMID: 32790222; PMCID: PMC7436614.
  12. Angel JCA, Martínez-Buitrago E, Posada-Vergara MP. COVID-19 and HIV. Colomb Med (Cali). 2020;51(2). doi: 10.25100/cm.v51i2.4327. PMID: 33012892; PMCID: PMC7518728.
  13. Amimo F, Lambert B, Magit A. What does the COVID-19 pandemic mean for HIV, Tuberculosis, and Malaria control? Trop Med Health. 2020;48:32. doi: 10.1186/s41182-020-00219-6. PMID: 32425653; PMCID: PMC7218555.
  14. Ogunleye OO, Basu D, Mueller D, Sneddon J, Seaton RA, Yinka-Ogunleye AF, et al. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front Pharmacol. 2020;11:1205. doi: 10.3389/fphar.2020.01205. PMID: 33071775; PMCID: PMC7533592.
  15. Kamal Mirkarimi S, Maghsoudloo M, Berdi Ozouni-Davaji R, Raeisi V, Charkazi A, Raeisi M. The Determinants of Hypertension and Commitment to Implementing a Nutrition Program: Application of Pender Health Promotion Model. J Health Lit. 2018;3(1):50-60.
  16. Mirahmadizadeh A, Rezaei F, Jokari K, Moftakhar L, Hemmati A, Dehghani SS, et al. Correlation between environmental factors and COVID-19 indices: a global level ecological study. Environ Sci Pollut Res Int. 2021:1-11. doi: 10.1007/s11356-021-16876-x. PMID: 34651278; PMCID: PMC8516493.
  17. Solhi M, Shirzad M. Situation of fruits and vegetables consumption in the dormitory female students based on the theory of planned behavior. J Health Lit. 2016;1(2):129-36.
  18. Bahrami S. Media Literacy Education on the attitude of the athletes about sports supplements (Case Study of Kermanshah fitness clubs). J Health Lit. 2018;3(2):104-12.
  19. Goodman S. Vitamin D Knowledge, Perceptions, Intake and Status among Young Adults: a Validation & Intervention Study Using A Mobile ‘App’ 2015.
  20. Navarra T. The encyclopedia of vitamins, minerals, and supplements: Infobase Publishing; 2014 May 14.
  21. Ibrahim N, Amit N, Shahar S, Wee L-H, Ismail R, Khairuddin R, et al. Do depression literacy, mental illness beliefs and stigma influence mental health help-seeking attitude? A cross-sectional study of secondary school and university students from B40 households in Malaysia. BMC Public Health. 2019;19(4):544. doi: 10.1186/s12889-019-6862-6. PMID: 31196033; PMCID: PMC6565530.
  22. Huang J, Xie N, Hu X, Yan H, Ding J, Liu P, et al. Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study. Clinical infectious diseases. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa1186. PMID: 32803216; PMCID: PMC7454403.
  23. Prabhu S, Poongulali S, Kumarasamy N. Impact of COVID-19 on people living with HIV: A review. J Virus Erad. 2020;6(4):100019. doi: 10.1016/j.jve.2020.100019. PMID: 33083001; PMCID: PMC7560116.
  24. Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, et al. Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia. AIDS (London, England). 2020;34(12):1789-94. doi: 10.1097/QAD.0000000000002632. PMID: 32675581; PMCID: PMC7484356.
  25. Ballester-Arnal R, Gil-Llario MD. The Virus that Changed Spain: Impact of COVID-19 on People with HIV. AIDS Behav. 2020;24(8):2253-7. doi: 10.1007/s10461-020-02877-3. PMID: 32342259; PMCID: PMC7184942.
  26. Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. lancet HIV. 2021;8(1):e24-e32. doi: 10.1016/S2352-3018(20)30305-2. PMID: 33316211; PMCID: PMC7773630.
  27. Ho HE, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, et al. Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus. J Infect Dis. 2021;223(3):403-8. doi: 10.1093/infdis/jiaa380. PMID: 32601704; PMCID: PMC7337732.
  28. Wu Q, Chen T, Zhang H. Recovery from the coronavirus disease-2019 (COVID-19) in two patients with coexisted (HIV) infection. J Med Virol. 2020;92(11):2325-7. doi: 10.1002/jmv.26006. PMID: 32401359; PMCID: PMC7272796.
  29. Calza L, Bon I, Tadolini M, Borderi M, Colangeli V, Badia L, et al. COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy. Infection. 2021;49(2):333-7. doi: 10.1007/s15010-020-01492-7. PMCID: PMC7397968.
  30. Morani Z, Patel S, Ghosh S, Hassan FA, Doreswamy S, Singh S, et al. COVID-19 in HIV: a review of published case reports. SN Compr Clin Med. 2020;2(12):2647-57. doi: 10.1007/s42399-020-00593-6. PMID: 33163861; PMCID: PMC7604227.
  31. Sala G, Miyakawa T. Association of BCG vaccination policy with prevalence and mortality of COVID-19. Medrxiv. 2020;10(2020.03):30.20048165.
  32. Tamuzi JL, Ayele BT, Shumba CS, Adetokunboh OO, Uwimana-Nicol J, Haile ZT, et al. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence. BMC Infect Dis. 2020;20(1):744. doi: 10.1186/s12879-020-05450-4. PMID: 33036570; PMCID: PMC7545798.
  33. Khurana AK, Aggarwal D. The (in)significance of TB and COVID-19 co-infection. Eur Respir J. 2020;56(2). doi: 10.1183/13993003.02105-2020. PMID: 32554537; PMCID: PMC7301834.
  34. Morani Z, Patel S, Ghosh S, Hassan FA, Doreswamy S, Singh S. COVID-19 in HIV: a Review of Published Case Reports. SN Compr Clin Med. 2020:1-11. doi: 10.1007/s42399-020-00593-6. PMID: 33163861; PMCID: PMC7604227.
  35. Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Raju RS. COVID-19-Tuberculosis interactions: When dark forces collide. Indian J Tuberc. 2020;67(4):S155-S62. doi: 10.1016/j.ijtb.2020.07.003. PMID: 33308662; PMCID: PMC7362784.
  36. Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y, Gu Y, Liu C, Fan L, Wang X, Cheng M. Active or latent Tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv. 2020 Mar 16:2020-03.
  37. Sy KTL, Haw NJL. Previous and active Tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond). 2020;52(12):902-7. doi: 10.1080/23744235.2020.1806353. PMID: 32808838.
  38. Hussein MIH, Albashir AAD, Elawad O, Homeida A. Malaria and COVID-19: unmasking their ties. Malar J. 2020;19(1):457. doi: 10.1186/s12936-020-03541-w. PMID: 33357220; PMCID: PMC7755982.
  39. Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Sara Raju R. COVID-19 -Tuberculosis interactions: When dark forces collide. Indian J Tuberc. 2020;67(4s):S155-s62. doi: 10.1016/j.ijtb.2020.07.003. PMID: 33308662; PMCID: PMC7362784.
  40. Harris R, Rosemurgy A. COVID-19 and Malaria: a fatal attraction for SARS CoV-2. J Epidemiol Public Health Rev. 2020;5(2).
  41. Arshad AR, Bashir I, Ijaz F, Loh N, Shukla S, Rehman UU, et al. Is COVID-19 Fatality Rate Associated with Malaria Endemicity? Discoveries (Craiova). 2020;8(4). doi: 10.15190/d.2020.17. PMID: 33365386; PMCID: PMC7749783.
  42. Michael UA. COVID-19 Mortality in Malaria Endemic Countries: An Ecological Study. 2021.